Achillion's (ACHN +3.2%) ACH-3102 medicine for chronic hepatitis C viral infections, in...

|About: Achillion Pharmaceuticals... (ACHN)|By:, SA News Editor

Achillion's (ACHN +3.2%) ACH-3102 medicine for chronic hepatitis C viral infections, in combination with antiviral drug ribavirin, has performed well so far in a Phase 2a study of 8 patients. The treatment "resulted in the rapid reduction in HCV RNA accompanied by normalization of liver enzymes." The combo also appears to be safe and well tolerated. (PR)